Cargando…
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Response criteria in acute myeloid leukemia (AML) has recently been re-established, with morphologic examination utilized to determine whether patients have achieved complete remission (CR). Approximately half of the adult patients who entered CR will relapse within 12 months due to the outgrowth of...
Autores principales: | Cloos, Jacqueline, Harris, Jeffrey R., Janssen, Jeroen J.W.M., Kelder, Angele, Huang, F., Sijm, Gerrit, Vonk, Maike, Snel, Alexander N., Scheick, Jennifer R., Scholten, Willemijn J., Carbaat-Ham, Jannemieke, Veldhuizen, Dennis, Hanekamp, Diana, Oussoren-Brockhoff, Yvonne J.M., Kaspers, Gertjan J.L., Schuurhuis, Gerrit J., Sasser, A. Kate, Ossenkoppele, Gert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931431/ https://www.ncbi.nlm.nih.gov/pubmed/29553571 http://dx.doi.org/10.3791/56386 |
Ejemplares similares
-
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML
por: Hanekamp, Diana, et al.
Publicado: (2021) -
Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia
por: Zeijlemaker, Wendelien, et al.
Publicado: (2019) -
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
por: Terwijn, Monique, et al.
Publicado: (2014) -
P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
por: Lam Ngai, Lok, et al.
Publicado: (2023) -
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
por: Hanekamp, Diana, et al.
Publicado: (2020)